PURCHASE ORDER
Active75N98026P00592
Department of Health and Human Services › National Institutes of Health › NATIONAL INSTITUTES OF HEALTH OLAO
$110K
obligated · signed 4 months ago
OUTSOURCING PCAS AND EPIDURALS FOR PATIENTS CARE FROM QUVA PHARMA, INC.
Performance timeline
Start
May 26, 2026
End
May 25, 2027
with all options
Loading status
This contract is likely in the recompete window
Ends with all options: May 25, 2027
QUVA PHARMA, INC.
Contract 75N98026P00592
UEI
MUABDCZXMLG4
Parent Company
QUVA PHARMA INC.
Capabilities & Certifications
Headquarters Location
Congressional District: 22
Current Obligation
$110,000
Base + Exercised Options
$110,000
Total Ceiling Value
$110,000
Contract Type
FIRM FIXED PRICE
NAICS
PHARMACEUTICAL PREPARATION MANUFACTURING
PSC
DRUGS AND BIOLOGICALS
Place of Performance
Congressional District: 08
Awarding Agency
Top-tier agency
National Institutes of Health
Sub-tier agency
NATIONAL INSTITUTES OF HEALTH OLAO
Office
Funding Agency
Top-tier agency
National Institutes of Health
Sub-tier agency
NATIONAL INSTITUTES OF HEALTH - CC
Office
Solicitation procedures, competition exceptions, labor standards and account totals.